Product category:
Nucleic acid sequencing and synthesis
News Release from: Applied Biosystems | Subject: TaqMan
Edited by the Laboratorytalk Editorial
Team on 07 November 2006
Value of TaqMan drug assays is validated
Scientists from Applied Biosystems presented data demonstrating superior accuracy of TaqMan drug metabolism genotyping assays in identifying variation in genes that code for drug metabolism enzymes
Identifying these variations is important in both drug development and clinical research, as they are associated with certain diseases such as cancer, and have been shown to significantly impact drug efficacy The data, presented at the 56th annual meeting of the American Society of Human Genetics, was based on the use of approximately 2400 markers from the TaqMan Drug Metabolism Enzyme panel examining genetic variation across the International HapMap Project and SNP500Cancer populations
This article was originally published on Laboratorytalk on 12 Feb 2004 at 8.00am (UK)
Related stories
High throughput system for carcinoma research
Scientists at Ceph turned to Applied Biosystems when they needed high throughput equipment to analyse differentially expressed genes in hepatocellular tumours
Assays were measured for their reproducibility, signal intensity, and the ability to make robust genotype calls.
Reference data from this study will be publicly available on the National Cancer Institute's SNP500Cancer website as well as the Pharmacogenomics Knowledge Base, a publicly available internet research tool to help researchers understand how genetic variation relates to individual differences in reactions to drugs.
• Applied Biosystems: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
